Free Trial
NASDAQ:BBNX

Beta Bionics (BBNX) Stock Price, News & Analysis

Beta Bionics logo
$22.90 +0.44 (+1.96%)
As of 04:00 PM Eastern

About Beta Bionics Stock (NASDAQ:BBNX)

Advanced

Key Stats

Today's Range
$21.97
$23.35
50-Day Range
$12.53
$26.41
52-Week Range
$8.89
$26.66
Volume
1.10 million shs
Average Volume
960,858 shs
Market Capitalization
$995.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.33
Consensus Rating
Moderate Buy

Company Overview

Beta Bionics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

BBNX MarketRank™: 

Beta Bionics scored higher than 18% of companies evaluated by MarketBeat, and ranked 863rd out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Beta Bionics has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 7 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Beta Bionics is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Beta Bionics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Beta Bionics' stock forecast and price target.
    • Percentage of Shares Shorted

      9.50% of the float of Beta Bionics has been sold short.
    • Short Interest Ratio / Days to Cover

      Beta Bionics has a short interest ratio ("days to cover") of 5.3.
    • Change versus previous month

    • Dividend Yield

      Beta Bionics does not currently pay a dividend.

    • Dividend Growth

      Beta Bionics does not have a long track record of dividend growth.

    • Percentage of Shares Shorted

      9.50% of the float of Beta Bionics has been sold short.
    • Short Interest Ratio / Days to Cover

      Beta Bionics has a short interest ratio ("days to cover") of 5.3.
    • Change versus previous month

    • News Sentiment

      Beta Bionics has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.
    • News Coverage This Week

      MarketBeat has tracked 4 news articles for Beta Bionics this week, compared to 4 articles on an average week.
    • Search Interest

      8 people have searched for BBNX on MarketBeat in the last 30 days.
    • MarketBeat Follows

      2 people have added Beta Bionics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
    • Insider Buying vs. Insider Selling

      In the past three months, Beta Bionics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $894,710.00 in company stock.

    • Read more about Beta Bionics' insider trading history.
    Receive BBNX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    BBNX Stock News Headlines

    Beta Bionics (NASDAQ:BBNX) Insider Sells $15,993.28 in Stock
    This is the “End of Tesla” as we know it…
    Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla call alone could have made readers 21 TIMES THEIR MONEY, if they listened to his recommendation. Don't miss his next big prediction.tc pixel
    See More Headlines

    BBNX Stock Analysis - Frequently Asked Questions

    Beta Bionics' stock was trading at $23.81 at the beginning of the year. Since then, BBNX shares have decreased by 3.8% and is now trading at $22.90.

    Beta Bionics, Inc. (NASDAQ:BBNX) issued its earnings results on Tuesday, July, 29th. The company reported ($0.39) EPS for the quarter, topping analysts' consensus estimates of ($0.51) by $0.12. The firm had revenue of $23.24 million for the quarter, compared to analyst estimates of $19.73 million.
    Read the conference call transcript
    .

    Beta Bionics (BBNX) raised $204 million in an IPO on Thursday, January 30th 2025. The company issued 12,000,000 shares at $17.00 per share.

    Beta Bionics's lock-up period expired on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its IPO on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period.

    Beta Bionics' top institutional shareholders include Eventide Asset Management LLC (11.35%), Soleus Capital Management L.P. (8.79%), Sands Capital Alternatives LLC (8.21%) and Divisadero Street Capital Management LP (2.18%). Insiders that own company stock include Hadley Harbor Aggre Wellington, Mike Mensinger, Steven Jon Russell, Stephen Feider and Mark Hopman.
    View institutional ownership trends
    .

    Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Company Calendar

    Last Earnings
    7/29/2025
    Today
    9/22/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED INSTRUMENTS
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:BBNX
    Previous Symbol
    NASDAQ:BBNX
    CIK
    1674632
    Web
    N/A
    Fax
    N/A
    Employees
    294
    Year Founded
    2015

    Price Target and Rating

    High Price Target
    $30.00
    Low Price Target
    $16.00
    Potential Upside/Downside
    +1.9%
    Consensus Rating
    Moderate Buy
    Rating Score (0-4)
    2.75
    Research Coverage
    12 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    14.68
    Quick Ratio
    13.79

    Sales & Book Value

    Annual Sales
    $65.12 million
    Price / Sales
    15.29
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    ($5.72) per share
    Price / Book
    -4.00

    Miscellaneous

    Outstanding Shares
    43,470,000
    Free Float
    N/A
    Market Cap
    $995.46 million
    Optionable
    N/A
    Beta
    N/A

    Social Links

    Ten Starter Stocks For Beginners to Buy Now Cover

    Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

    Get This Free Report

    This page (NASDAQ:BBNX) was last updated on 9/22/2025 by MarketBeat.com Staff
    From Our Partners